Multidrug-resistant Neisseria gonorrhoeae.
作者信息
Tapsall John
机构信息
World Health Organization Collaborating Centre for Sexually Transmitted Diseases, Microbiology Department, The Prince of Wales Hospital, Sydney, Australia.
出版信息
CMAJ. 2009 Feb 3;180(3):268-9. doi: 10.1503/cmaj.081721.
Abstract
摘要
相似文献
1
Multidrug-resistant Neisseria gonorrhoeae.
CMAJ. 2009 Feb 3;180(3):268-9. doi: 10.1503/cmaj.081721.
2
Emerging international strain of multidrug-resistant : Infection in a man with urethral discharge.
Can Fam Physician. 2019 Aug;65(8):552-554.
3
Multidrug-resistant Neisseria gonorrhoeae: future therapeutic options.
Future Microbiol. 2018 Apr;13:499-501. doi: 10.2217/fmb-2017-0258. Epub 2018 Mar 8.
4
Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden.
Sex Transm Infect. 2010 Nov;86(6):454-60. doi: 10.1136/sti.2010.045377.
5
Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006.
J Antimicrob Chemother. 2008 Jan;61(1):150-5. doi: 10.1093/jac/dkm434. Epub 2007 Nov 6.
6
Emergence of multidrug-resistant Neisseria gonorrhoeae strains circulating worldwide.
Int J Urol. 2012 Feb;19(2):98-9. doi: 10.1111/j.1442-2042.2011.02891.x. Epub 2011 Dec 13.
7
Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.
Expert Rev Anti Infect Ther. 2009 Sep;7(7):821-34. doi: 10.1586/eri.09.63.
8
The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health.
Sex Transm Infect. 2012 Aug;88(5):317-8. doi: 10.1136/sextrans-2012-050674.
9
Multidrug Resistance in Neisseria gonorrhoeae: Identification of Functionally Important Residues in the MtrD Efflux Protein.
mBio. 2019 Nov 19;10(6):e02277-19. doi: 10.1128/mBio.02277-19.
10
Prospects of untreatable gonorrhea and ways forward.
Future Microbiol. 2015;10(3):313-6. doi: 10.2217/fmb.14.138.
引用本文的文献
1
-Susceptibility Trends and Basic Molecular Mapping of Isolates Collected in Israel in 2016-2022.
Microorganisms. 2025 Mar 26;13(4):750. doi: 10.3390/microorganisms13040750.
2
Antimicrobial Resistance Profiles of Human Commensal Species.
Antibiotics (Basel). 2021 May 6;10(5):538. doi: 10.3390/antibiotics10050538.
3
Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.
PLoS Med. 2017 Jul 26;14(7):e1002366. doi: 10.1371/journal.pmed.1002366. eCollection 2017 Jul.
4
Management of gonococcal infection among adults and youth: New key recommendations.
Can Fam Physician. 2015 Oct;61(10):869-73, e451-6.
5
Origin and proliferation of multiple-drug resistance in bacterial pathogens.
Microbiol Mol Biol Rev. 2015 Mar;79(1):101-16. doi: 10.1128/MMBR.00039-14.
6
Global fluoroquinolone resistance epidemiology and implictions for clinical use.
Interdiscip Perspect Infect Dis. 2012;2012:976273. doi: 10.1155/2012/976273. Epub 2012 Oct 14.
7
Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States.
Emerg Infect Dis. 2012 Aug;18(8):1290-7. doi: 10.3201/eid1808.111202.
8
Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil.
J Clin Microbiol. 2011 Dec;49(12):4208-12. doi: 10.1128/JCM.01175-11. Epub 2011 Oct 5.
9
Cephalosporin Resistance in Neisseria gonorrhoeae.
J Glob Infect Dis. 2010 Sep;2(3):284-90. doi: 10.4103/0974-777X.68537.
10
Increased expression of the type IV secretion system in piliated Neisseria gonorrhoeae variants.
J Bacteriol. 2010 Apr;192(7):1912-20. doi: 10.1128/JB.01357-09. Epub 2010 Feb 5.
本文引用的文献
1
Prevalence of and risk factors for quinolone-resistant Neisseria gonorrhoeae infection in Ontario.
CMAJ. 2009 Feb 3;180(3):287-90. doi: 10.1503/cmaj.080222.
2
Molecular epidemiological identification of Neisseria gonorrhoeae clonal clusters with distinct susceptibility profiles associated with specific groups at high risk of contracting human immunodeficiency virus and syphilis.
J Clin Microbiol. 2008 Dec;46(12):3931-4. doi: 10.1128/JCM.00577-08. Epub 2008 Oct 8.
3
Lack of nationwide surveillance of antimicrobial resistance of Neisseria gonorrhoeae in Japan.
Ann Intern Med. 2008 Sep 2;149(5):363-4. doi: 10.7326/0003-4819-149-5-200809020-00025.
4
Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection.
Antimicrob Agents Chemother. 2008 Oct;52(10):3564-7. doi: 10.1128/AAC.00198-08. Epub 2008 Jul 28.
5
Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies.
Ann Intern Med. 2008 Apr 15;148(8):606-13. doi: 10.7326/0003-4819-148-8-200804150-00005.
6
Using strain typing to characterise a fluoroquinolone-resistant Neisseria gonorrhoeae transmission network in southern California.
Sex Transm Infect. 2008 Aug;84(4):290-1. doi: 10.1136/sti.2008.030163. Epub 2008 Mar 13.
7
Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006.
J Antimicrob Chemother. 2008 Jan;61(1):150-5. doi: 10.1093/jac/dkm434. Epub 2007 Nov 6.
8
Identification of individuals with gonorrhoea within sexual networks: a population-based study.
Lancet. 2006 Jul 8;368(9530):139-46. doi: 10.1016/S0140-6736(06)69003-X.
9
Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003.
Clin Infect Dis. 2005 Sep 15;41(6):795-803. doi: 10.1086/432801. Epub 2005 Aug 12.
10
The antimicrobial resistance containment and surveillance approach--a public health tool.
Bull World Health Organ. 2004 Dec;82(12):928-34. Epub 2005 Jan 5.
Zotero 插件